Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Kolaviron and quercetin may help treat prostate issues.

Diphenylcyclopropenone (DPCP) can help regrow hair in many alopecia areata patients but may cause side effects and relapses.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Inhibiting TYK2 can restore hair growth in alopecia areata.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Krill oil may help reduce prostate enlargement and growth.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Blocking certain proteins in mouse skin can reduce and shrink skin tumors.

Effective PCOS treatments require targeting specific signaling pathways.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

DPCP works best for alopecia areata, but more research is needed for better treatments.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

The combined therapy improved fertility in women with PCOS, especially in certain types.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Many patients on new leukemia drugs had mild to moderate skin reactions.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.